Registre des publications 

Tous les résultats des travaux de recherche de l'IFCT, même négatifs, ont vocation à etre publiés dans des journaux médicaux de premier plan. Ces résultats font aussi l’objet de présentations orales et posters lors des congrès scientifiques de référence. Parmi ces congrès figurent notamment ceux de l'ASCO, ESMO et du WCLC.

 

145 IFCT_NOMBRE_RESULTATS

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Herbreteau G, Langlais A, Greillier L, Audigier-Valette C, Uwer L, Hureaux J, Moro-Sibilot D, Guisier F, Carmier D, Madelaine J, Otto J, Souquet PJ, Gounant V, Merle P, Molinier O, Renault A, Rabeau A, Morin F, Denis MG, Pujol JL
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Clinical Medicine
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Blons H, Oudart J-B, Merlio J-P, Debieuvre D, de Fraipont F, Audigier-Valette C, Escande F, Hominal S, Bringuier P‐P, Fraboulet-Moreau S, Ouafik L, Moro-Sibilot D, Lemoine A, Langlais A, Missy P, Morin F, Souquet P-J, Barlesi F, Cadranel J, Beau‐Faller M
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Lièvre A, Turpin A, Ray-Coquard I.L., Le Malicot K, Thariat J, Ahle G, Mathieu R, Sebbagh V, Debieuvre D, Canellas A, Garcia-Larnicol M, Colle R, Hardy-Bessard A, Mansi L, Bourhis J, Gorphe P, Ursu R, Idbaih A, Zalcman G, Bouche O, Aparicio T
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Ruppert, A-M, Beau-Faller M, Debieuvre D, Ouafik L, Westeel V, Rouquette I, Mazières J, Bringuier P-P, Monnet I, Escande F, Ricordel C, Merlio J-P, Janicot H., Lemoine A, Foucher P, Poudenx M, Morin F, Langlais A, Souquet P-J, Barlesi F, Wislez M,
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Audigier-Valette C, Lavolé A, Molinier O, Westeel V, Barlesi F, Le Treut J, Pichon E, Dauba J, Otto J, Moreau L, Madelaine J, Dumont P, Margery J, Debieuvre D, Renault PA, Pujol JL, Langlais A, Morin F, Moro-Sibilot D, Souquet PJ.
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Lavole A, Greillier L, Mazières J, Monnet I, Kiakouama-Maleka L, Quantin X, Spano JP, Lena H, Fraisse P, Janicot H, Audigier-Valette C, Langlais A, Morin F, Makinson A, Cadranel J; French Cooperative Thoracic Intergroup (IFCT).
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Kembou Nzale S, Weeks WB, Ouafik L, Rouquette I, Beau-Faller M, Lemoine A, Bringuier PP, Le Coroller Soriano AG, Barlesi F, Ventelou B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
PLOS One
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Cortot AB, Audigier-Valette C, Molinier O, Le Moulec S, Barlesi F, Zalcman G, Dumont P, Pouessel D, Poulet C, Fontaine-Delaruelle C, Hiret S, Dixmier A, Renault PA, Becht C, Raffy O, Dayen C, Mazieres J, Pichon E, Langlais A, Morin F, Moro-Sibilot D, Besse B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Fontaine-Delaruelle C, Mazières J, Cadranel J, Mastroianni B, Dubos-Arvis C, Dumont P, Monnet I, Pichon E, Locatelli-Sanchez M, Dixmier A, Coudert B, Fraboulet S, Foucher P, Dansin E, Baize N, Vincent M, Missy P, Morin F, Moro-Sibilot D, Couraud S; IFCT10-02 BioCAST investigators
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Respiratory Medicine and Research
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Mazieres J, Barlesi F, Rouquette I, Molinier O, Besse B, Monnet I, Audigier-Valette C, Toffart AC, Renault PA, Fraboulet S, Hiret S, Mennecier B, Debieuvre D, Westeel V, Masson P, Madroszyk-Flandin A, Pichon E, Cortot AB, Amour E, Morin F, Zalcman G, Moro-Sibilot D, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Clinical Cancer Research
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Mazieres J, Cropet C, Montané L, Barlesi F, Souquet PJ, Quantin X, Dubos-Arvis C, Otto J, Favier L, Avrillon V, Cadranel J, Moro-Sibilot D, Monnet I, Westeel V, Le Treut J, Brain E, Trédaniel J, Jaffro M, Collot S, Ferretti GR, Tiffon C, Mahier-Ait Oukhatar C, Blay JY
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID

The GCO-002 CACOVID-19 cohort: a French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
A. Lièvre, A. Turpin, I.L. Ray-Coquard, K. Le Malicot, J. Thariat, G. Ahle, R. Mathieu, V. Sebbagh, D. Debieuvre, A. Canellas, M-L. Garcia-Larnicol, R. Colle, A-C. Hardy-Bessard, L. Mansi, J. Bourhis, P. Gorphe, R. Ursu, A. IDBAIH Ahmed, G. Zalcman, O. Bouche,
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
S. Peters, J. Pujol, U. Dafni, M. Dómine, A. Becker, J. Andrade, A. Curioni-Fontecedro, O. Molinier, D. Moro-Sibilot, K. Nackaerts, A. Insa Mollá, G. López Vivanco, J. Madelaine, S. Popat, M. Reck, H. Roschitzki-Voser, P. Mitchell, D. De Ruysscher, C. Le Pechoux, R. Stahel
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients (pts) with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement. Primary end-point analysis of Lung ART (IFC

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
C. Le Pechoux, N. Pourel, F. Barlesi, C. Faivre-Finn, D. Lerouge, G. Zalcman, D. Antoni, B. Lamezec, U. Nestle, P. Boisselier, F. Thillays, A. Paumier, E. Dansin, K. Peignaux, J. Madelaine, E. Pichon, A. Larrouy, O. Riesterer, A. Lavole, A. Bardet
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
M. Wislez, J. Mazieres, A. Lavole, G. Zalcman, O. Carre, T. Egenod, R. Caliandro, R. Gervais, G. Jeannin, O. Molinier, M.A. Massiani, A. Langlais, F. Morin, F. Le Pimpec Barthes, L. Brouchet, J. Assouad, B. Milleron, D. Damotte, M. Antoine, V. Westeel
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Lorlatinib for advanced ALK and ROS1+ non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Simon Baldacci, Virginie Avrillon, Benjamin Besse, Bertrand Mennecier, Michael Duruisseaux, Julien Mazieres, Renaud Descourt, Helene Doubre, Pascale Dubray-Longeras, Jacques Cadranel, Denis Moro-Sibilot, Charles Ricordel, Sigolène Galland-Girodet, Isabelle Monnet, Josiane Otto, Sophie Schneider, Pascale Missy, Franck Morin, Virginie Westeel, Nicolas Girard
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2020
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the Fren

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Beau-Faller M, Pencreach E, Leduc C, Blons H, Merlio JP, Bringuier PP, de Fraipont F, Escande F, Lemoine A, Ouafik L, Denis M, Hofman P, Lacave R, Melaabi S, Langlais A, Missy P, Morin F, Moro-Sibilot D, Barlesi F, Cadranel J; French Cooperative Thoracic Intergroup (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Dubois F, Keller M, Hoflack J, Maille E, Antoine M, Westeel V, Bergot E, Quoix E, Lavolé A, Bigay-Game L, Pujol JL, Langlais A, Morin F, Zalcman G, Levallet G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Cancers
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Baldacci S, Figeac M, Antoine M, Descarpentries C, Kherrouche Z, Jamme P, Copin MC, Tulasne D, Nanni I, Beau-Faller M, Melaabi S, Levallet G, Quoix E, Moro-Sibilot D, Friard S, Missy P, Barlesi F, Cadranel J, Cortot AB
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Moro-Sibilot D, Cozic N, Pérol M, Mazières J, Otto J, Souquet PJ, Bahleda R, Wislez M, Zalcman G, De Guibert S, Barlési F, Mennecier B, Monnet I, Sabatier R, Bota S, Dubos C, Verriele V, Haddad V, Ferretti G, Cortot A, De Fraipont F, Jimenez M, Hoog-Labouret N, Vassal G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Brosseau S, Danel C, Scherpereel A, Mazières J, Lantuejoul S, Margery J, Greillier L, Audigier-Valette C, Gounant V, Antoine M, Moro-Sibilot D, Rouquette I, Molinier O, Corre R, Monnet I, Langlais A, Morin F, Bergot E, Zalcman G, Levallet G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Clinical Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Barlesi F, Fontaine-Deraluelle C, Debieuvre D, Merlio JP, Moreau L, Beau-Faller M, Veillon R, Mosser J, Al Freijat F, Bringuier PP, Léna H, Ouafik L, Westeel V, Morel A, Audigier-Valette C, Missy P, Langlais A, Morin F, Souquet PJ, Planchard D; Biomarkers France Contributors
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

ST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Maille E, Brosseau S, Hanoux V, Creveuil C, Danel C, Bergot E, Scherpereel A, Mazières J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Langlais A, Morin F, Levallet G, Zalcman G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
British Journal of cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Scherpereel A, Mazieres J, Greillier L, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, Audigier-Valette C, Locatelli-Sanchez M, Molinier O, Guisier F, Urban T, Ligeza-Poisson C, Planchard D, Amour E, Morin F, Moro-Sibilot D, Zalcman G, on behalf of the French Cooperative Thoracic Intergroup
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
The Lancet Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

A Randomized Non-Comparative Phase 2 Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients with Small Cell Lung Cancer: Results from the IFCT 1603 Trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Greillier L, Audigier-Valette C, Moro-Sibilot D, Uwer L, Hureaux J, Guisier F, Carmier D, Madelaine J, Otto J, Gounant V, Merle P, Mourlanette P, Molinier O, Renault A, Rabeau A, Antoine M, Denis MG, Bommart S, Langlais A, Morin F, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Phase II randomized trial of afatinib with or without cetuximab as first-line treatment for EGFR mutated non-small cell lung cancer (NSCLC) patients (IFCT-1503 ACE-Lung)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Cortot A B, Madroszyk A, Giroux Leprieur E, Molinier O, Quoix E, Berard H, Otto J, Rault I, Raimbourg J, Hureaux J, Moreau L, Debieuvre D, Morel H, Denis M, Amour E, Morin F, Moro-Sibilot D, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
Poster
IFCT_PUBLICATIONS_CONCERNEE

Second/third-line nivolumab vs nivo plus ipilimumab in malignant pleural mesothelioma: Long-term results of IFCT-1501 MAPS2 phase IIR trial with a focus on hyperprogression (HPD)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Zalcman G, Mazieres J, Greillier L, Brosseau S, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, Audigier-Valette C, Locatelli-Sanchez M, Molinier O, Guisier F, Urban T, Planchard D, Ligeza-Poisson C, Amour A, Morin F, Moro-Sibilot D, Scherpereel A.
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Etude de phase II randomisée non comparative de l'anti-PD-L1 atézolizumab versus chimiothérapie comme traitement de deuxième ligne chez les patients atteints d'un cancer du poumon à petites cellules (CBPC) : résultats de l'essai IFCT-1603

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Greillier L, Audigier-Valette C, Moro-Sibilot D, Uwer L, Hureaux J,Thiberville L, Carmier D, Madelaine J, Otto J, Gounant V, Merle P, Mourlanette P, Molinier O, Renault A, Mazieres J, Antoine M, Langlais A, Morin F, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
CPLF
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

IFCT-1702 IMPACT-SEPSIS Impact d’un événement infectieux significatif sur le pronostic des patients atteints d’un cancer bronchique non à petites cellules avancées traités par chimiothérapie de 1re ligne

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
A.C. Toffart, E. Quoix, M. Pérol, R. Stéphane, Q. Tran, P.J. Souquet, J.F. Timsit,
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
CPLF
IFCT_PUBLICATIONS_ANNEE_YEAR
2019
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

A randomized non-comparative phase II study of anti–PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 Trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Greillier L, Audigier-Valette C, Moro-Sibilot D, Uwer L, Hureaux J,Thiberville L, Carmier D, Madelaine J, Otto J, Gounant V, Merle P, Mourlanette P, Molinier O, Renault A, Mazieres J, Antoine M, Langlais A, Morin F, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Beau-Faller M, Texier M, Blons H, Richard N, Escande F, Melaabi S, Lizard S, De Fraipont F, Longchampt E, Morin F, Zalcman G, Pignon JP, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Clinical Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID

IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Mignard X, Antoine M, Moro-Sibilot D, Dayen C, Mennecier B, Gervais R, Amour E, Milleron B, Morin F, Zalcman G, Wislez M
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID

Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Merveilleux du Vignaux C, Dansin E, Mhanna L, Greillier L, Pichon E, Kerjouan M, Clement-Duchene C, Mennecier B, Westeel V, Robert M, Quantin X, Zalcman G, Thiberville L, Lena H, Molina T, Calcagno F, Fournel P, Mazieres J, Besse B, Girard N
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Loubière S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J; French Cooperative Thoracic Intergroup (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Bennouna J, Barlesi F, Do P, Dumont P, Cadranel J, Debieuvre D, Hilgers W, Molinier O, Quoix E, Raimbourg J, Langlais A, Morin F, Souquet P.J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO open
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette, Benjamin Besse, Isabelle Monnet, Clarisse Audigier-Valette, Anne Claire Toffart, Patrick-Aldo Renault, Severine Moreau Fraboulet, Sandrine Hiret, Bertrand Mennecier, Didier Debieuvre, Virginie Westeel, Philippe Masson, Anne Madroszyk, Elodie Amour, Franck Morin, Gerard Zalcman, Denis Moro-Sibilot, Pierre Jean Souquet, French Cooperative
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced nonsmall cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase 3 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Audigier-Valette C, Lavolé A, Molinier O, Westeel V, Barlesi F, Le Treut J, Pichon E, Dauba J, Otto J, Moreau L, Madelaine J, Dumont P, Margery J, Debieuvre D, Renault PA, Langlais A, Morin F, Moro-Sibilot D, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2018
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Structuring the French Thoracic Oncology over the Last 20 Years

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID

Association between lung cancer somatic mutations and occupational exposure in never-smokers

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Paris C, Do P, Mastroianni B, Dixmier A, Dumont P, Pichon E, Chouaid C, Coudert B, Foucher P, Fraboulet S, Locatelli-Sanchez M, Baize N, Dansin E, Moreau L, Vincent M, Missy P, Morin F, Moro-Sibilot D, Couraud S; BioCAST/IFCT-1002 study investigators; to the BioCAST/IFCT- 1002 study
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID

Clinical and molecular characteristics of non-small cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Leduc C, Merlio JP, Besse B, Blons H, Debieuvre D, Bringuier PP, Monnet I, Rouquette I, Fraboulet-Moreau S, Lemoine A, Pouessel D, Mosser J, Vaylet F, Langlais A, Missy P, Morin F, Moro-Sibilot D, Cadranel J, Barlesi F, Beau-Faller M; French Cooperative Thoracic Intergroup (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Current knowledge on perioperative treatments of non-small cell lung carcinomas

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Brosseau S, Naltet C, Nguenang M, Gounant V, Mordant P, Milleron B, Castier Y, Zalcman G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Tomasini P, Brosseau S, Mazières J, Merlio J.P, Beau-Faller M, Mosser J, Wislez M, Ouafik L, Besse B, Rouquette I, Debieuvre D, Escande F, Westeel V, Audigier-Valette C, Missy P, Langlais A, Morin F, Moro-Sibilot D, Zalcman G, Barlesi F
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID

Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Negrouk A, Lacombe D, Cardoso F, Morin F, Carrasco E, Maurel J, Maibach R, Aranda E, Marais R, Stahel R
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO open
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID

Clinical research activity of the French cancer cooperative network: Overview and perspectives

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Dubois C, Morin F, Moro-Sibilot D, Langlais A, Seitz JF, Girault C, Salles G, Haioun C, Deschaseaux P, Casassus P, Mathiot C, Pujade-Lauraine É, Votan B, Louvet C, Delpeut C, Bardet É, Vintonenko N, Hoang Xuan K, Vo M, Michon J, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Bulletin du cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK) : a French nationwide cohort retrospective study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Duruisseaux M, Besse B, Cadranel J, Pérol M, Mennecier B, Bigay-Game L, Descourt R, Dansin E, Audigier-Valette C, Moreau L, Hureaux J, Veillon R, Otto J, Madroszyk-Flandin A, Cortot A, Guichard F, Boudou-Rouquette P, Langlais A, Missy P, Morin F, Moro-Sibilot D
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Oncotarget
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Besse B, Mazières J, Ribassin-Majed L, Barlesi F, Bennouna J, Gervais R, Moreau L, Berard H, Debieuvre D, Molinier O, Moro-Sibilot D, Souquet PJ, Jacquot S, Petit L, Lena H, Pignon JP, Lacas B, Morin F, Milleron B, Zalcman G, Soria JC; Intergroupe Francophone de Cancérologie Thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Guibert N, Barlesi F, Descourt R, Léna H, Besse B, Beau-Faller M, Mosser J, Pichon E, Merlio JP, Ouafik L, Guichard F, Mastroianni B, Moreau L, Wdowik A, Sabourin JC, Lemoine A, Missy P, Langlais A, Moro-Sibilot D, Mazieres J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
V. Westeel, F. Barlesi, P. Foucher, J.-J. Lafitte, J. Domas, P. Girard, J. Tredaniel, M. Wislez, P. Dumont, E. Quoix, O. Raffy, D. Braun, M. Derollez, F. Goupil, J. Hermann, E. Devin, E. Pichon, J.-P. Gury, F. Morin, P.-J. Souquet
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Arnaud Scherpereel, Julien Mazieres, Laurent Greillier, Pascal Dô, Olivier Bylicki, Isabelle Monnet, Romain Corre, Clarisse Audigier-Valette, Myriam Locatelli-Sanchez, Olivier Molinier, Luc Thiberville, Thierry Urban, Catherine Ligeza-poisson, David Planchard, Elodie Amour, Franck Morin, Denis Moro-Sibilot, Gerard Zalcman
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

IFCT-GFPC-1101 trial: A multicenter phase III assessing a maintenance strategy determined by response to induction chemotherapy compared to continuation maintenance with pemetrexed in patients (pts) with advanced non-squamous (NSQ) NSCLC

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Maurice Perol, Clarisse Audigier-Valette, Olivier Molinier, Alexis B. Cortot, Jacques Margery, Lionel Moreau, Virginie Westeel, Pascal Dô, Fabrice Barlesi, Eric Pichon, Gerard Zalcman, Patrick Dumont, Nicolas Girard, Michel Poudenx, Julien Mazieres, Jacques Cadranel, Didier Debieuvre, Jérôme Dauba, Denis Moro-Sibilot, Pierre Jean Souquet
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Second or 3rd line Nivolumab (Nivo) versus Nivo plus Ipilimumab (Ipi) in Malignant Pleural Mesothelioma (MPM) patients: updated results of the IFCT-1501 MAPS2 randomized phase 2 trial.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Zalcman G, Mazieres J, Greillier L, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, Audigier-Valette C, Locatelli-Sanchez M, Molinier O, Thiberville L, Urban T, Planchard D, Ligeza-Poisson C, Amour A, Morin F, Moro-Sibilot D, Scherpereel A
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Prevalence of Autoimmune Diseases in Thymic Epithelial Tumors (TET) Insights from RYTHMIC

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
ME. Boucher, E. Dansin, M. Kerjouan, J. Mazieres, E. Pichon, F. Thillays, G. Massard, X. Quantin, O. Youssef, V. Westeel, L. Thiberville, C. Clement-Duchene, F. Morin, P. Thomas, N. Girard, B. Besse
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
WCLC
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Recurrences and 2Nd Primary Cancers in the IFCT-0302 Trial Assessing a CT-Scan-Based Follow-Up after Lung Cancer Surgery

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
V. Westeel, F. Barlesi, P. Foucher, J. Lafitte, J. Domas, P. Girard, J. Trédaniel, M. Wislez, B. Chahine, J. Muir, S. Dehette, J. Virally, M. Grivaux, F. Lebargy, F. Al Freijat, Nicolas Girard, E. Courau, R. Azarian, M. Farny, J. Duhamel, S. Labrune, F. Morin, P.J. Souquet
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
WCLC
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

IFCT-1502 CLINIVO: Real-Life Experience with Nivolumab in 600 Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
N. Girard, O. Molinier, C. Audigier-Valette, J. Cadranel, I. Monnet, J. Hureaux, W. Hilgers, E. Fauchon, E. Fabre, Benjamin Besse, P. Brun, D. Coëtmeur, E. Quoix, P. Mourlanette, Fabrice Barlesi, S. Bordenave-Caffre, T. Egenod, P. Missy, F. Morin, D. Moro-Sibilot
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
WCLC
IFCT_PUBLICATIONS_ANNEE_YEAR
2017
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Levallet G, Dubois F, Fouret P, Antoine M, Brosseau S, Bergot E, Beau-Faller M, Gounant V, Brambilla E, Debieuvre D, Molinier O, Galateau-Sallé F, Mazieres J, Quoix E, Pujol JL, Moro-Sibilot D, Langlais A, Morin F, Westeel V, Zalcman G.
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Oncotarget
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Lung Cancer Screening with Chest Computed Tomography in People Living with HIV. A Review by the Multidisciplinary CANCERVIH Working Group

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Makinson A, Le Moing V, Reynes J, Ferry T, Lavole A, Poizot-Martin I, Pujol JL, Spano JP, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Remon J, Girard N, Mazieres J, Dansin E, Pichon E, Grellier L, Dubos C, Lindsay CR, Besse B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Pujol JL, Sabourin JC, Penault-Llorca F, Denis MG, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria JC, Zalcman G; Biomarkers France contributors
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
The Lancet
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

Sensitivity to chemotherapy/tyrosine kinase inhibitors of mucinous lepidic adenocarcinoma should be tested in a phase III trial?

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Cadranel J, Wislez M, Langlais A, Morin F, Zalcman G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID

Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 0201

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Fournel P, Vergnenégre A, Robinet G, Léna H, Gervais R, Le Caer H, Souquet PJ, Chavaillon JM, Bozonnat MC, Daurès JP, Chouaid C, Martel-Lafay I; GFPC and IFCT team
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID

Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): Results from the phase III study IFCT-1103 ULTIMATE

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlesi, Gerard Zalcman, Patrick Dumont, Damien Pouessel, Claire Poulet, Pierre Jean Souquet, Sandrine Hiret, Adrien Dixmier, Patrick-Aldo Renault, Alexandra Langlais, Marie Paule Lebitasy, Franck Morin, Denis Moro-Sibilot, Benjamin Besse
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Clinical and biological characteristics of non-small cell lung cancer (NSCLC) harbouring EGFR mutation: Results of the nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Leduc C, Blons H, Besse B, Merlio JP, Debieuvre D, Lemoine A, Monnet I, Pouessel D, Bringuier PP, , Poudenx M, Rouquette I, Vaylet F, Langlais A, Missy P, Morin F, Quoix E, Moro-Sibilot D, Cadranel J, Barlesi F, Beau-Faller M
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ESMO
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE
BF

IFCT-1001 CHIVA trial : A phase II study of carboplatin (Ca) plus pemetrexed (P) followed by P maintenance, as first-line therapy for human immunodeficiency virus (HIV)–associated advanced non-squamous non-small cell lung cancer (NS-NSCLC)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Armelle Lavole, Pascale Tomasini, Isabelle Monnet, Lize Kiakouama-Maleka, Xavier Quantin, Laurent Taillade, Hervé Lena, Philippe Fraisse, Henri Janicot, Clarisse Audigier-Valette, Alain Makinson, Alexandra Langlais, Marie Paule Lebitasy, Franck Morin, Jacques Cadranel
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Pathological central review of 290 thymic epithelial tumors (TET) : The national network RYTHMIC experience.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Thierry Molina, Maria Virginia Bluthgen, Lara Chalabreysse, Vincent Thomas De Montpreville, Anne De Muret, Veronique Hofman, Sylvie Lantuejoul, Marie Parrens, Isabelle Rouquette, Veronique Secq, Nicolas Girard, Alexander Marx, Benjamin Besse
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

A phase II study assessing the benefit of cisplatin re-introduction (stop and go strategy) in patients with advanced non-squamous non-small cell lung cancer (NSCLC) : The IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Fabrice Barlesi, Judith Raimbourg, Pascal Do, Patrick Dumont, Jacques Cadranel, Didier Debieuvre, Werner Hilgers, Pierre Jean Souquet, Olivier Molinier, Elisabeth A. Quoix, Alexandra Langlais, Marie Paule Lebitasy, Franck Morin, Gerard Zalcman, Jaafar Bennouna
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2016
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Milleron B, Westeel V, Gounant V, Wislez M, Quoix E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Bulletin du cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Reply to the letter to the editor 'Prevalence of rare EGFR mutations in non-small cell lung cancer: a multicenter study on 3856 Polish Caucasian patients' by Krawczyk et al.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Beau-Faller M, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID

Pathological complete response: A predictive survival factor after neoadjuvant chemotherapy in lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Milleron B, Westeel V, Gounant V, Wislez M, Quoix E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Bulletin du cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID

Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Cadranel J, Gervais R, Merle P, Moro-Sibilot D, Westeel? V,Bigay-Game L, Quoix E, Friard S, Barlesi F, Lethrosne C, Moreau L, Monnet I, Salaun M, Oliviero G, Souquet PJ, Antoine M, Langlais A, Morin F, Wislez M, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et al

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Morin F, Zalcman G; IFCT
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Moro-Sibilot D, Audigier-Valette C, Merle P, Quoix E, Souquet PJ, Barlesi F, Chouaid C, Molinier O, Bennouna J, Lavolé A, Mazières J, Toffart AC, Langlais A, Morin F, Zalcman G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Randomized Phase II-III Study of Bevacizumab in Combination with Chemotherapy in Previously Untreated Extensive Small-Cell Lung Cancer: Results from the IFCT-0802 Trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Lavole A, Quoix E, Molinier O, Souquet PJ, Barlesi F, Le Caer H, Moro-Sibilot D, Fournel P, Oster JP, Chatellain P, Barre P, Jeannin G, Mourlanette P, Derollez M, Herman D, Renault A, Dayen C, Lamy PJ, Langlais A, Morin F, Zalcman G; French Cooperative Thoracic Intergroup (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Debieuvre D, Moreau L, Dumont P, Margery J, Quoix E, Duvert B, Cellerin L, Baize N, Taviot B, Coudurier M, Cadranel J, Missy P, Morin F, Mornex JF, Zalcman G, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID

Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Des Guetz G, Landre T, Westeel V, Milleron B, Vaylet F, Urban T, Barlesi F, Souquet PJ, Debieuvre D, Braun D, Fraboulet G, Monnet I, Uzzan B, Molinier O, Morin F, Moro-Sibilot D, Morère JF
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Geriatric Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Souquet PJ, Paris C, Dô P, Doubre H, Pichon E, Dixmier A, Monnet I, Etienne-Mastroianni B, Vincent M, Trédaniel J, Perrichon M, Foucher P, Coudert B, Moro-Sibilot D, Dansin E, Labonne S, Missy P, Morin F, Blanché H, Zalcman G; on behalf of The French Cooperative Intergroup IFCT
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID

Bevacizumab 15mg/kg plus cisplatin-pemetrexed (CP) triplet versus CP doublet in Malignant Pleural Mesothelioma (MPM): Results of the IFCT-GFPC-0701 MAPS randomized phase 3 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Gerard Zalcman , Julien Mazières , Jacques Margery , Laurent Greillier , Clarisse Audigier-Valette , Denis Moro-SibilotOliver Molinier , Romain Corre , Isabelle Monnet , Valérie Gounant , Henri Janicot , Radj Gervais , Chrystele Locher , Bernard Milleron , Quan Tran , Marie Paule Lebitasy , Franck Morin , Christian Creveuil , Jean-Jacques Parienti , Arnaud Scherpereel ,
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2015
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Borget I, Pérol M, Pérol D, Lavolé A, Greillier L, Dô P, Westeel V, Crequit J, Léna H, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Chabaud S, Vergnenegre A, Zalcman G, Chouaïd C
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
BMC Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Calvayrac O, Pradines A, Raymond-Letron I, Rouquette I, Bousquet E, Lauwers-Cances V, Filleron T, Cadranel J, Beau-Faller M, Casanova A, Milia J, Favre G, Mazières J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Clinical Cancer Research
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Vaca-Paniagua F, Villar S, Oliver J, Schuster T, Blanché H, Girard, N, Trédaniel J, Guilleminault L, Gervais R, Prim N, Vincent M, Margery J, Larivé S, Foucher P, Duvert B, Vallee M, Le Calvez-Kelm F, McKay J, Missy P, Morin F, Zalcman G, Olivier M, Souquet PJ; BioCAST/IFCT-1002 investigators
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Clinical Cancer Research
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Estimating overdiagnosis in lung cancer screening

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Greillier L, Milleron B; IFCT Lung Cancer Screening Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
JAMA internal Medicine
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

Customized Adjuvant Phase II Trial in Patients With Non-Small-Cell Lung Cancer: IFCT-0801 TASTE

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Wislez M, Barlesi F, Besse B, Mazières J, Merle P, Cadranel J, Audigier-Valette C, Moro-Sibilot D, Gautier-Felizot L, Goupil F, Renault A, Quoix E, Souquet PJ, Madroszyck A, Corre R, Pérol D, Morin F, Zalcman G, Soria JC
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Clinical Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Lung cancer and HIV infection

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Lavolé A, Toper C, Belmont L, Ruppert AM, Wislez M, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Girard N, Gounant V, Mennecier B, Greillier L, Cortot AB, Couraud S, Besse B, Brouchet L, Castelnau O, Ferretti GR, Frappé P, Khalil A, Lefebure P, Laurent F, Liebart S, Margery J, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; groupe de travail multidisciplinaire de l’Intergroupe francophone de cancérologie thoracique, de la Société d’imagerie thoracique et du Groupe d’oncologie de langue française
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Beau-Faller M, Prim N, Ruppert AM, Nanni-Metéllus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Crémoux P, Solassol J, de Fraipont F, Bièche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Legrain M, Voegeli AC, Baudrin L, Morin F, Zalcman G, Quoix E, Blons H, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

A Multicenter Blinded Study Evaluating EGFR and KRAS Mutation Testing Methods in the Clinical Non-Small Cell Lung Cancer Setting-IFCT/ERMETIC2 Project Part 1: Comparison of Testing Methods in 20 French Molecular Genetic National Cancer Institute Platforms

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
The Journal of Molecular Diagnostics
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

National multidisciplinary tumor board (MTB): Report of the first 526 questions raised within RYTHMIC, the network for thymic malignancies in France.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Benjamin Besse , Eric Pichon , Eric Dansin , Pascal Alexandre Thomas , Hervé Lena , Gerard ZalcmanJulien Mazieres , Gilbert Massard , Luc Thiberville , Virginie Westeel , Xavier Quantin , Christelle Clement-Duchene , Pierre Fournel , Hélène Senellart , Quan Tran , Thierry Jo Molina , Nicolas Girard
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

Second-line therapy in elderly patients with advanced non-small cell lung carcinoma: analysis of the IFCT-0501 Phase III study comparing single-agent therapy to carboplatin-based doublet therapy with fixed second-line erlotinib therapy.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Westeel V, Moreau L, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Sennelart H, Tredaniel J, Mennecier B, Morin F, Baudrin L, Milleron B, Zalcman G; on behalf of Intergroupe Francophone de CancérologieThoracique
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
J. Trédaniel, F. Mornex
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
Oral abstract
IFCT_PUBLICATIONS_CONCERNEE

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Jean-Louis Pujol , Armelle Lavole , Bertrand Mennecier , Oliver Molinier , Pierre Jean Souquet , Fabrice BarlesiHerve Le Caer , Denis Moro-Sibilot , Pierre Fournel , Jean-Philippe Oster , Patrick Chatellain , Patricia Barre , Gaelle Jeannin , Pierre Mourlanette , Marc Derollez , Dominique Herman , Patrick Renault , Charles Dayen , Franck Morin , Gerard Zalcman
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Biomarker-driven access to crizotinib in ALK-, MET-, or ROS1-positive malignancies in adults and children: Feasibility of the French National Acsé Program

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Gilles Vassal , Natalie Hoog Labouret , Marie-Cécile Le Deley , Marta Jimenez , Frederique Nowak , Denis Moro-SibilotYann Godbert , Luc Taillandier , Jean-Yves Blay , Herve R. Bonnefoi , David Malka , Roch Houot , Thomas Aparicio , Bernard J. Escudier , Christophe Tournigand , Isabelle Ray Coquard , Pierre Laurent-Puig , Frederique Madeleine Penault-Llorca , Fabien M. Calvo , Agnes Buzyn
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2014
IFCT_PUBLICATIONS_PMID

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Westeel V, Quoix E, Puyraveau M, Lavolé A, Braun D, Laporte S, Bigay-Game L, Pujol JL, Ozenne G, Rivière A, Douillard JY, Lebeau B, Debieuvre D, Poudenx M, David P, Molinier O, Zalcman G, Lemarié E, Morin F, Depierre A, Milleron B; IFCT (Intergroupe Francophone de Cancérologie Thoracique)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

From the NLST randomized trial to the clinic: How should we implement individual lung cancer screening in clinical practice?

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Barlesi F, Lemarié E, Zalcman G, Milleron B; pour le groupe de travail IFCT/GOLF sur le dépistage du cancer broncho-pulmonaire
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d’Oncologie de langue française

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
S. Couraud, A. Cortot, L. Greillier, V. Gounant, B. Mennecier, N. Girard, B. Besse, L. Brouchet, O. Castelnau, P. Frappé, G. Ferretti, L. Guittet, A. Khalil, P. Lefebure, F. Laurent, S. Liebart, O. Molinier, E. Quoix, M-P. Revel, B. Stach, P-J. Souquet, P. Thomas, J. Trédaniel, E. Lemarié, G. Zalcman, F. Barlesi, B. Milleron on behalf of the French lung cancer screening statement taskforce.
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID

Reply to letter EJC-D-13-01186

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Westeel V, Quoix E, Zalcman G, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID

Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Bylicki O, Ferlay C, Chouaid C, Lavolé A, Barlési F, Dubos C, Westeel V, Créquit J, Corre R, Vergnenègre A, Monnet I, Le Caer H, Fournel P, Vaylet F, Falchero L, Poudenx M, Linard P, Pérol D, Zalcman G, Pérol M
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Lung cancer in never smokers: A French national cohort (BioCAST/IFCT-1002)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Labonne S, Missy P, Morin F, Tran Q, Deroy A, Milleron B, Blanché H, Zalcman G, Souquet PJ; les membres du Groupe de travail « non-fumeurs de l’IFCT »
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, Coll JL, Hurbin A
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
International Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2013
IFCT_PUBLICATIONS_PMID

Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar Carcinoma): Exploratory Analysis of the IFCT-0401 Trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Duruisseaux M, Baudrin L, Quoix E, Wislez M, Moro-Sibilot D, Coëtmeur D, Monnet I, Mourlanette P, Morère JF, Soria JC, Westeel V, Morin F, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Clinical Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Randomized, Phase III Study (IFCT-GFPC 0502) of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pérol M, Chouaid C, Pérol D, Barlési F, Gervais R, Westeel V, Crequit J, Léna H, Vergnenègre A, Zalcman G, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Ségura-Ferlay C, Devouassoux-Shisheboran M, Taron M, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Clinical Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Professional Exposure to Goats Increases the Risk of Pneumonic-Type Lung Adenocarcinoma: Results of the IFCT-0504-Epidemio Study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Lutringer-Magnin D, Girard N, Cadranel J, Leroux C, Quoix E, Cottin V, Signore CD, Lebitasy MP, Cordier G, Vanhems P, Mornex JF
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
PLOS One
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Lung cancer in never smokers - A review

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Journal of Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID

High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non-Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, de Fraipont F, Brambilla E, Levallet J, Morin F, Westeel V, Wislez M, Quoix E, Debieuvre D, Dubois F, Rouquette I, Pujol JL, Moro-Sibilot D, Camonis J, Zalcman G; on behalf of the Intergroupe Francophone de Cancérologie Thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Molecular Cancer Therapeutics
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID

Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Mouillet G, Monnet E, Milleron B, Puyraveau M, Quoix E, David P, Ducoloné A, Molinier O, Zalcman G, Depierre A, Westeel V; Intergroupe Francophone de Cancérologie Thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID

An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
De Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B, Zalcman G; on behalf of the Intergroupe Francophone de Cancérologie Thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Clinical Cancer Research
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Cost-effectiveness of three strategies for second-line erlotinib initiation in non small-cell lung cancer: the ERMETIC Study Part 3

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Borget I, Cadranel J, Pignon JP, Quoix E, Coudert B, Westeel V, Dansin E, Madelaine J, Madroszyk A, Friard S, Daniel C, Morin F, Chouaid C; the ERMETIC Collaborative Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Journal
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Therapeutic options in older patients with metastatic non-small cell lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Therapeutic Advances in Medical Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID

Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project-Part 2)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Cadranel J, Mauguen A, Faller M, Zalcman G, Buisine MP, Westeel V, Longchampt E, Wislez M, Coudert B, Daniel C, Chetaille B, Michiels S, Blons H, Solassol J, De Fraipont F, Foucher P, Urban T, Lacroix L, Poulot V, Quoix E, Antoine M, Danton G, Morin F, Chouaid C, Pignon JP
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2012
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Chemotherapy in elderly patients with advanced non-small cell lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Westeel V, Zalcman G, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID

Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Hurbin A, Wislez M, Busser B, Antoine M, Tenaud C, Rabbe N, Dufort S, de Fraipont F, Moro-Sibilot D, Cadranel J, Coll JL, Brambilla E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal Pathology
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for th

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Beau-Faller M, Degeorges A, Rolland E, Mounawar M, Antoine M, Poulot V, Mauguen A, Barbu V, Coulet F, Prétet JL, Bièche I, Blons H, Boyer JC, Buisine MP, de Fraipont F, Lizard S, Olschwang S, Saulnier P, Prunier-Mirebeau D, Richard N, Danel C, Brambilla E, Chouaid C, Zalcman G, Hainaut P, Michiels S, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B; Intergroupe Francophone de Cancérologie Thoracique
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
The Lancet
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Non-small cell lung carcinoma: Perspectives for the twenty-first century ?

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Presse Médicale
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID

Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Ducoloné A, Mennecier B, Fraisse P
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Presse Médicale
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Tredaniel J, Mornex F, Barillot I, Diaz O, Hennequin C, Le Pechoux C, Lavole A, Giraud P, Souquet PJ, Teixeira L, Vaylet F, Zalcman G, Baudrin L, Morin F, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Le Péchoux C, Laplanche A, Faivre-Finn C, Ciuleanu T, Wanders R, Lerouge D, Keus R, Hatton M, Videtic GM, Senan S, Wolfson A, Jones R, Arriagada R, Quoix E, Dunant A; on behalf of the Prophylactic Cranial Irradiation (PCI) Collaborative Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Annals of Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Pemetrexed re-challenge in pleural malignant mesothelioma: An option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Zalcman G, Bergot E, Lechapt E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID

Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Bergot E, Levallet G, Creveuil C, Lechapt E, Zalcman G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Presse Médicale
IFCT_PUBLICATIONS_ANNEE_YEAR
2011
IFCT_PUBLICATIONS_PMID

Update on nonsmall cell lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Zalcman G, Bergot E, Lechapt E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
European Respiratory Review
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID

The role of pemetrexed in lung adenocarcinoma, mixed subtype with bronchioloalveolar carcinoma features

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Duruisseaux M, Cadranel J, Pérol M, Arpin D
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Current drug Targets
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Morère JF, Bréchot JM, Westeel V, Gounant V, Lebeau B, Vaylet F, Barlési F, Urban T, Souquet PJ, Debieuvre D, Baudrin L, Zalcman G, Morin F, Milleron B, Moro-Sibilot
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Wislez M, Antoine M, Baudrin L, Poulot V, Neuville A, Pradere M, Longchampt E, Isaac-Sibille S, Lebitasy MP, Cadranel J
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Girard N, Mornex F, Douillard JY, Bossard N, Quoix E, Beckendorf V, Grunenwald, Amour E, Milleron B.
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Lung Cancer
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
E. A. Quoix , J. Oster , V. Westeel , E. Pichon , G. Zalcman , L. BaudrinA. Lavole , J. Dauba , M. Lebitasy , B. J. Milleron , on behalf of IFCT
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
ASCO
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Management and outcome of French elderly patients with lung cancer: an IFCT survey

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E, Monnet I, Scheid P, Hamadouche A, Chouaid C, Massard G, Depierre A, Souquet PJ, Braun D, Girard P, Breton JL, Lebitasy MP, Milleron B; l'Intergroupe francophone de cancérologie thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2010
IFCT_PUBLICATIONS_PMID

IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Cadranel J, Quoix E, Baudrin L, Mourlanette P, Moro-Sibilot D, Morere JF, Souquet PJ, Soria JC, Morin F, Milleron B; IFCT-0401 Trial Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2009
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a r

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A; Prophylactic Cranial Irradiation (PCI) Collaborative Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
The Lancet Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2009
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Patient participation in thoracic cancer clinical trials

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Chakra M, Milleron B
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2008
IFCT_PUBLICATIONS_PMID

How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Moro-Sibilot D, Barlesi F, Timsit JF, Debieuvre D, Fournel P, Gervais R, Mazieres J, Milleron B, Morin F, Perol M, Soria JC, Souquet PJ, Vergnenègre A, Zalcman G
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2008
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

IFCT-0302 trial: Randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pujol JL, Breton JL, Gervais R, Tanguy ML, Quoix E, David P, Janicot H, Westeel V, Gameroff S, Geneve J, Maraninchi D
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Clinical Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID
IFCT_PUBLICATIONS_CONCERNEE

The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Pieter E. Postmus, MD, PhD; Elisabeth Brambilla, MD, PhD; Kari Chansky, MS; John Crowley, PhD; Peter Goldstraw, MB, FRCS; Edward F. Patz Jr, MD; Hiroyasu Yokomise, MD; on behalf of the International Association for the Study of Lung Cancer International Staging Committee,a Cancer Research and Biostatistics,b Observers to the Committee,c and Participating Institutions
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Ramón Rami-Porta, MD; David Ball, MD, FRANZCR; John Crowley, PhD; Dorothy J. Giroux, MS; James Jett, MD; William D. Travis, MD; Masahiro Tsuboi, MD; Eric Vallières, MD; Peter Goldstraw, MB, FRCS; on behalf of the International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Peter Goldstraw, FRCS; John Crowley, PhD; Kari Chansky, MS; Dorothy J. Giroux, MSc; Patti A. Groome, PhD; Ramon Rami-Porta, MD; Pieter E. Postmus, PhD; Valerie Rusch, MD; Leslie Sobin, MD; on behalf of the International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Ramón Rami-Porta, MD; David Ball, MD, FRANZCR; John Crowley, PhD; Dorothy J. Giroux, MS; James Jett, MD; William D. Travis, MD; Masahiro Tsuboi, MD; Eric Vallières, MD; Peter Goldstraw, MB, FRCS; on behalf of the International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Patti A. Groome, PhD; Vanessa Bolejack, MPH; John J. Crowley, PhD; Catherine Kennedy, RMRA; Mark Krasnik, MD; Leslie H. Sobin, MD; Peter Goldstraw, FRCS; on Behalf of the International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee and Participating Institutions
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Thoracic Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Moro-Sibilot D, Pluquet E, Zalcman G, Bréchot JM, Souquet PJ, Debieuvre D, Morin F, Morère JF
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

Standards, Options and Recommendations (SOR) for the Perioperative Treatment of Patients With Resectable and operable Non-Small Cell Lung Cancer (updated)

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
B. Besse, A. Depierre, S. Guillo, C. Séblain-El Guerche, J-Y. Douillard, A. Giniès, C. Hennequin, C. Le Péchoux, B. Milleron, P. Mouillefarine, E. Quoix, D. Moro-Sibilot, J-F. Regnard, M. Riquet, F. Vaylet, G. Zalcman ; Fédération nationale des centres de lutte contre le cancer (FNCLCC) - Intergroupe Francophone de Cancerologie Thoracique (IFCT) - Société de pneumologie de langue française (SPLF)
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2007
IFCT_PUBLICATIONS_PMID

Follow up of non small cell lung cancer. Should patients be followed up after surgery for non-small cell lung cancer and how?

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Westeel V
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue des Maladies Respiratoires
IFCT_PUBLICATIONS_ANNEE_YEAR
2006
IFCT_PUBLICATIONS_PMID

Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Milleron B, Westeel V, Quoix E, Moro-Sibilot D, Braun D, Lebeau B, Depierre A; French Thoracic Cooperative Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Chest
IFCT_PUBLICATIONS_ANNEE_YEAR
2005
IFCT_PUBLICATIONS_PMID

French clinical research in thoracic oncology

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Morin F
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Revue de Pneumologie Clinique
IFCT_PUBLICATIONS_ANNEE_YEAR
2004
IFCT_PUBLICATIONS_PMID

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C; French Thoracic Cooperative Group
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Journal of Clinical Oncology
IFCT_PUBLICATIONS_ANNEE_YEAR
2002
IFCT_PUBLICATIONS_PMID

IFCT --French Intergroup of Thoracic Cancerology: presentation, protocols

IFCT_PUBLICATIONS_AUTEURS_AUTHORS
Quoix E
IFCT_PUBLICATIONS_JOURNAL_CONFERENCE
Cancer Radiothérapie
IFCT_PUBLICATIONS_ANNEE_YEAR
2001
IFCT_PUBLICATIONS_PMID